Profund Advisors LLC Halozyme Therapeutics, Inc. Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 41,370 shares of HALO stock, worth $2.18 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

41,370

Previous 29,431 40.57%

Holding current value

$2.18 Million

Previous $1.54 Million 53.54%

% of portfolio

0.09%

Previous 0.06%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$51.3 - $64.42 $612,470 - $769,110	11,939 Added 40.57%	41,370 $2.37 Million
Q2 2024 Aug 13, 2024	SELL	$37.81 - $52.4 $450,506 - $624,346	-11,915 Reduced 28.82%	29,431 $1.54 Million
Q1 2024 May 08, 2024	SELL	$33.68 - $41.95 $52,473 - $65,358	-1,558 Reduced 3.63%	41,346 $1.68 Million
Q4 2023 Feb 14, 2024	SELL	$33.32 - $42.1 $44,915 - $56,750	-1,348 Reduced 3.05%	42,904 $1.59 Million
Q3 2023 Nov 13, 2023	SELL	$36.46 - $44.03 $217,629 - $262,815	-5,969 Reduced 11.89%	44,252 $1.69 Million
Q2 2023 Aug 10, 2023	BUY	$30.28 - $38.74 $402,512 - $514,970	13,293 Added 36.0%	50,221 $1.81 Million
Q1 2023 May 11, 2023	BUY	$32.86 - $55.7 $467,137 - $791,831	14,216 Added 62.59%	36,928 $1.41 Million
Q4 2022 Feb 02, 2023	SELL	$40.06 - $59.44 $3,044 - $4,517	-76 Reduced 0.33%	22,712 $1.29 Million
Q3 2022 Nov 04, 2022	SELL	$38.53 - $51.78 $17,030 - $22,886	-442 Reduced 1.9%	22,788 $901,000
Q2 2022 Aug 01, 2022	SELL	$37.35 - $48.3 $148,951 - $192,620	-3,988 Reduced 14.65%	23,230 $1.02 Million
Q1 2022 May 10, 2022	SELL	$31.97 - $41.06 $98,915 - $127,039	-3,094 Reduced 10.21%	27,218 $1.09 Million
Q4 2021 Feb 08, 2022	SELL	$31.82 - $40.75 $119,484 - $153,016	-3,755 Reduced 11.02%	30,312 $1.22 Million
Q3 2021 Nov 12, 2021	BUY	$38.47 - $46.42 $878,808 - $1.06 Million	22,844 Added 203.55%	34,067 $1.39 Million
Q2 2021 Aug 12, 2021	BUY	$38.84 - $51.31 $11,923 - $15,752	307 Added 2.81%	11,223 $511,000
Q1 2021 May 14, 2021	SELL	$39.51 - $51.45 $59,699 - $77,740	-1,511 Reduced 12.16%	10,916 $455,000
Q4 2020 Feb 09, 2021	BUY	$25.81 - $43.62 $320,740 - $542,065	12,427 New	12,427 $531,000

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Halozyme Therapeutics, Inc. Transaction History